Auxly Cannabis (CBWTF) Stock News

Auxly Cannabis Group (OTCQB:CBWTF) has scheduled its Q2 2025 earnings release for August 14, 2025, before market open. The company will report results for both the second quarter and the six-month period ending June 30, 2025.

The company announced it will not hold an earnings conference call and does not plan to reinstate earnings calls in the near future. Investors are directed to send their inquiries to IR@auxly.com.

Auxly Cannabis Group (OTCQB: CBWTF) has successfully completed two transformative financial transactions that significantly strengthen its balance sheet and financial position. The company has eliminated $21 million in debt and secured an amended credit facility with BMO, which includes a $36.2 million term loan and a $10 million revolving facility.

The company has also settled all obligations with Imperial Brands through a combination of share conversions and warrant issuances. This settlement included converting $1 million principal amount into shares at $0.81 per share, converting $1.39 million of accrued interest into shares at $0.0811 per share, and issuing warrants for 90.8 million shares in exchange for approximately $7.37 million of additional interest, with $11.79 million in remaining interest forgiven.

Auxly Cannabis Group (CBWTF) has announced two significant financial agreements to strengthen its balance sheet and reduce debt. First, the company entered a non-binding agreement to amend its BMO-led credit facility, which includes a $50.7M facility consisting of a $36.2M term loan, $10M revolving facility, and $4.5M in equipment leases. Second, Auxly reached an exchange agreement with Imperial Brands to settle over $21M in convertible debenture debt through share issuance and pre-funded warrants. The agreement includes converting $1M principal into 1.23M shares at $0.81/share, $1.39M of accrued interest into shares at $0.0811/share, and issuing warrants for up to 90.88M shares. Upon completion, Imperial Brands will own approximately 19.9% of outstanding shares. These transactions aim to improve Auxly's capital structure, reduce interest obligations, and enhance financial stability.

Auxly Cannabis Group (CBWTF) has announced its Annual General Meeting of Shareholders scheduled for June 30, 2025, at 10:00 a.m. EST. The meeting will be held at McCarthy Tétrault LLP offices in Toronto. Due to limited seating, shareholders must pre-register via email at IR@auxly.com at least 48 hours before the meeting to attend in person. The company will provide an audio teleconference for remote attendance through North American Toll Free: 1-888-699-1199. However, shareholders participating via teleconference cannot vote during the meeting and are encouraged to vote in advance according to the instructions in the Management Information Circular, available on SEDAR+ and the company's website.

Auxly Cannabis Group (CBWTF) reported strong Q1 2025 financial results with net revenues of $32.7 million, up 29% year-over-year. The company achieved an Adjusted EBITDA of $7.4 million (23% of net revenue), representing a 232% increase from Q1 2024. Gross margin improved to 48%, up from 38% in 2024. The company reported net income of $12.1 million, compared to a loss of $26 million in Q1 2024. Back Forty emerged as Canada's #1 cannabis brand, with Auxly holding the #4 position among Canadian Licensed Producers with 5.8% market share. The company reduced debt by 5% from end of 2024 and maintained $17.1 million in cash at quarter end. Sales were driven by dried flower and pre-roll products (63% of revenue), with 75% of sales originating from British Columbia, Alberta, and Ontario.

Auxly Cannabis Group Inc. (TSX: XLY) (OTCQB: CBWTF) has announced it will release its Q1 2025 financial results on Thursday, May 15, 2025, before market open. The company has stated it will not hold an earnings conference call and does not plan to reinstate earnings calls in the near future. Investors are directed to send their inquiries to IR@auxly.com.

Auxly Cannabis Group (CBWTF) reported strong financial results for Q4 and full year 2024, achieving record sales and profitability. Net revenue reached $122.3 million for the year, up 21% from 2023, with Q4 revenue of $34.6 million, increasing 29% year-over-year.

Key financial highlights include improved gross margins on finished cannabis inventory (54% in Q4 2024 vs 40% in 2023), reduced SG&A expenses by 8% to $35.7 million, and Adjusted EBITDA of $26.7 million (22% of net revenue). The company significantly strengthened its balance sheet by reducing total debt by 56% through conversion of over $123 million into shares.

Notable operational achievements include:

• Back Forty becoming the #1 cannabis brand in Canada by end of 2024
• 4th largest Canadian Licensed Producer with 6.0% market share
• Leading position in non-infused pre-roll category
• Back Forty all-in-one vape winning 'Innovation of the Year' at 2024 KIND awards

Auxly Cannabis Group (TSX: XLY) (OTCQB: CBWTF) has announced it will release its Q4 and full-year 2024 financial results on March 20, 2025, before market open. The company has stated it will not hold an earnings conference call and does not plan to reinstate earnings calls until further notice. Investors are directed to send inquiries to IR@auxly.com.

Auxly Cannabis Group (OTCQB: CBWTF) reported record-breaking Q3 2024 financial results with net revenues of $33.3 million, up 18% year-over-year. The company achieved a gross margin of 47% and record adjusted EBITDA of $8.3 million. Net income was $3.2 million with operating cash flow of $12.9 million. The company reduced its debt by 54% compared to end of 2023. Auxly moved to #4 position in national recreational sales, leading the all-in-one vape category with 36% market share. Back Forty's Liquid Imagination became the #1 selling flower nationally, while pre-roll sales increased 19% quarter-over-quarter.